Nelonemdaz sodium

SynDRA canonical compound SYN0045417 — structure-anchored drug synonym record

Clinical phase	Phase 2
Primary target(s)	GRIN1 \| GRIN2A \| GRIN2B \| GRIN2C \| GRIN2D \| GRIN3A \| GRIN3B
Mechanism of action	ionotropic glutamate receptor antagonist

Cross-references